Open AccessProtective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats
Author(s) -
Ahmed M. Atwa,
Rehab Hegazy,
Rania Mohsen,
Nemat Yassin,
Sanaa A. Kenawy
Publication year - 2017
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2017.173
Subject(s) - medicine , nebivolol , hepatorenal syndrome , oxidative stress , bilirubin , endocrinology , nitric oxide , pharmacology , kidney , cirrhosis , blood pressure
Renal dysfunction is very common in patients with advanced liver cirrhosis and portal hypertension. The development of renal failure in the absence of clinical, anatomical or pathological causes renal of failure is termed hepatorenal syndrome (HRS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom